Related references
Note: Only part of the references are listed.The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study
Andy K. W. Chan et al.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES (2015)
Epidemiology of Hepatocellular Carcinoma
Kelly J. Lafaro et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Transarterial Chemoembolization vs. Radiofrequency Ablation for the Treatment of Single Hepatocellular Carcinoma 2 cm or Smaller
Jong Woo Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Survival Advantage of Radiofrequency Ablation Over Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Good Performance Status Within the Milan Criteria
Po-Hong Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma
Xin Yin et al.
BMC CANCER (2014)
Radiofrequency ablation combined with transarterial chemoembolization for intermediate hepatocellular carcinoma
Masatoshi Tanaka et al.
HEPATOLOGY RESEARCH (2014)
Small Single-Nodule Hepatocellular Carcinoma: Comparison of Transarterial Chemoembolization, Radiofrequency Ablation, and Hepatic Resection by Using Inverse Probability Weighting
Hyo-Joon Yang et al.
RADIOLOGY (2014)
Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis
Shushan Yan et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis
Jia-yan Ni et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
Zhen-Wei Peng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma
Yong Li et al.
MEDICAL ONCOLOGY (2013)
IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients
Mostafa K. El Awady et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma
Jia-Yan Ni et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hepatocellular carcinomas 2-3 cm in diameter: Transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone
Jong Woo Kim et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas
Takashi Yamanaka et al.
JAPANESE JOURNAL OF RADIOLOGY (2012)
Recurrent Hepatocellular Carcinoma Treated with Sequential Transcatheter Arterial Chemoembolization and RF Ablation versus RF Ablation Alone: A Prospective Randomized Trial
Zhen-Wei Peng et al.
RADIOLOGY (2012)
Medium-Sized (3.1-5.0 cm) Hepatocellular Carcinoma: Transarterial Chemoembolization Plus Radiofrequency Ablation Versus Radiofrequency Ablation Alone
Jin Hyoung Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Repeated Radiofrequency Ablation for Management of Patients with Cirrhosis with Small Hepatocellular Carcinomas: A Long-Term Cohort Study
Sandro Rossi et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma Within the Milan Criteria: A Propensity Score Analysis
Chia-Yang Hsu et al.
LIVER TRANSPLANTATION (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Midterm Outcomes in Patients With Intermediate-Sized Hepatocellular Carcinoma
Manabu Morimoto et al.
CANCER (2010)
A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma
Z-W. Peng et al.
EJSO (2010)
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis
Giacomo Germani et al.
JOURNAL OF HEPATOLOGY (2010)
Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis
Wei Wang et al.
LIVER INTERNATIONAL (2010)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Percutaneous Thermal Ablation of Medium and Large Hepatocellular Carcinoma Long-Term Outcome and Prognostic Factors
Xiao-Yu Yin et al.
CANCER (2009)
Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment
Wei Yang et al.
HEPATOLOGY RESEARCH (2009)
Transarterial Injection of 131I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer
Laura Marelli et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Small Hepatocellular Carcinoma: Is Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization More Effective than Radiofrequency Ablation Alone for Treatment?
Toshiya Shibata et al.
RADIOLOGY (2009)
Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC
Po Yang et al.
ADVANCES IN THERAPY (2008)
Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?
Tito Livraghi et al.
HEPATOLOGY (2008)
Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: Rate and risk factors for local recurrence
Tomonori Murakami et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization
Kenneth S. Chok et al.
ARCHIVES OF SURGERY (2006)
Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)
A Veltri et al.
EUROPEAN RADIOLOGY (2006)
Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma
Chung-Bao Hsieh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4cm
SM Lin et al.
GASTROENTEROLOGY (2004)
Combined interventional therapies of hepatocellular carcinoma
J Qian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Prognostic prediction and treatment strategy in hepatocellular carcinoma
J Bruix et al.
HEPATOLOGY (2002)
Radiofrequency ablatian of 231 unresectable hepatic tumors: Indications, limitations, and complications
TF Wood et al.
ANNALS OF SURGICAL ONCOLOGY (2000)
Share Paper
